DE602005021388D1 - Verfahren für die präventive behandlung von allergien durch verabreichung einer allergie-vakzine auf die schleimhäute - Google Patents

Verfahren für die präventive behandlung von allergien durch verabreichung einer allergie-vakzine auf die schleimhäute

Info

Publication number
DE602005021388D1
DE602005021388D1 DE602005021388T DE602005021388T DE602005021388D1 DE 602005021388 D1 DE602005021388 D1 DE 602005021388D1 DE 602005021388 T DE602005021388 T DE 602005021388T DE 602005021388 T DE602005021388 T DE 602005021388T DE 602005021388 D1 DE602005021388 D1 DE 602005021388D1
Authority
DE
Germany
Prior art keywords
allergen
preventive treatment
allergy
administering
subject
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE602005021388T
Other languages
German (de)
English (en)
Inventor
Jens Brimnes
Jens Kildsgaard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ALK Abello AS
Original Assignee
ALK Abello AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35840082&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE602005021388(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by ALK Abello AS filed Critical ALK Abello AS
Publication of DE602005021388D1 publication Critical patent/DE602005021388D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE602005021388T 2004-11-10 2005-11-08 Verfahren für die präventive behandlung von allergien durch verabreichung einer allergie-vakzine auf die schleimhäute Expired - Lifetime DE602005021388D1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US62645404P 2004-11-10 2004-11-10
DKPA200401730 2004-11-10
US68691405P 2005-06-03 2005-06-03
PCT/DK2005/000716 WO2006050729A2 (en) 2004-11-10 2005-11-08 Method of preventive treatment of allergy by mucosal administration of an allergy vaccine

Publications (1)

Publication Number Publication Date
DE602005021388D1 true DE602005021388D1 (de) 2010-07-01

Family

ID=35840082

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005021388T Expired - Lifetime DE602005021388D1 (de) 2004-11-10 2005-11-08 Verfahren für die präventive behandlung von allergien durch verabreichung einer allergie-vakzine auf die schleimhäute

Country Status (10)

Country Link
US (1) US20060121064A1 (https=)
EP (1) EP1812059B1 (https=)
JP (1) JP5628473B2 (https=)
AT (1) ATE468135T1 (https=)
AU (1) AU2005304107B2 (https=)
CA (1) CA2586283A1 (https=)
DE (1) DE602005021388D1 (https=)
MX (1) MX2007005523A (https=)
PL (1) PL1812059T3 (https=)
WO (1) WO2006050729A2 (https=)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20080070851A (ko) * 2005-11-04 2008-07-31 알크-아벨로 에이/에스 구강점막 투여용 액상 알레르기 백신 제형의 용도
EP2240202A2 (en) * 2008-01-08 2010-10-20 ALK-Abelló A/S Allergy vaccine composition for mucosal administration
DE202008006598U1 (de) * 2008-04-11 2008-10-02 Alk-Abelló A/S Allergie-Impfstoff-Formulierung zur mucosalen Verabreichung
WO2010009417A1 (en) * 2008-07-17 2010-01-21 John Shea Method for testing and treating delayed food allergies
US10080810B2 (en) 2008-07-17 2018-09-25 John Shea Method for testing and treating delayed food allergies
WO2011137422A2 (en) 2010-04-30 2011-11-03 Apellis Pharmaceuticals, Inc. Methods and articles for preventing or reducing risk of developing a hyperallergenic immune system
JP6062851B2 (ja) * 2010-04-30 2017-01-18 アロヴェイト・エルエルシー 口腔粘膜を介してアレルギーを減感作するための方法、物品及びキット
US20120100163A1 (en) * 2010-10-15 2012-04-26 Alk-Abello A/S Suppression of a type 1 hypersensitivity immune response with an unrelated antigen
KR20130118884A (ko) * 2010-10-15 2013-10-30 알크-아벨로 에이/에스 알레르겐 소스 물질로부터 유도된 무관련 알레르겐을 이용한 과민성 면역반응의 억제
FI20115374A0 (fi) 2011-04-18 2011-04-18 Teknologian Tutkimuskeskus Vtt Oy Uudet hypoallergeenit
FI20115375A0 (fi) 2011-04-18 2011-04-18 Teknologian Tutkimuskeskus Vtt Oy Uudet hypoallergeenit
EP2952200A1 (en) 2014-06-04 2015-12-09 Alk-Abelló A/S Allergen for prophylactic treatment of allergy
KR101858840B1 (ko) * 2016-01-15 2018-05-16 단국대학교 천안캠퍼스 산학협력단 집먼지진드기 유래 알레르겐에 의한 과민반응 면역조절제
FI128016B (en) 2018-01-04 2019-07-31 Desentum Oy Recombinant hypoallergenic Ecu c1 polypeptides for use in horse allergy immunotherapy
CN110531059A (zh) * 2019-09-27 2019-12-03 中国海洋大学 一种食物过敏原动态消化模型和体外模拟评价方法
US20240042017A1 (en) * 2021-02-02 2024-02-08 My-Or Diagnostics Ltd. Methods for preventing oral sensitization
CN115735854B (zh) * 2022-11-15 2025-02-11 中国农业大学 一种榛子食物过敏的动物模型构建方法
AU2024305143A1 (en) 2023-06-12 2026-01-08 Desentum Oy Hypoallergenic variants of major peanut allergen, ara h 2

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63159324A (ja) * 1986-12-22 1988-07-02 Lion Corp スギ花粉症用経口ワクチン
AUPM307793A0 (en) * 1993-12-22 1994-01-20 Holt, Patrick G Professor Prophylaxis of allergic disease
JPH09315998A (ja) * 1996-05-30 1997-12-09 Japan Tobacco Inc スギ花粉症の予防および／または治療剤
JP2003517452A (ja) * 1999-02-05 2003-05-27 アルク−アベル・アー／エス 新規粘膜デリバリーシステム
US20030175312A1 (en) * 2000-11-16 2003-09-18 Alk-Abello A/S Novel mutant allergens
CN1668737A (zh) * 2002-05-16 2005-09-14 阿尔克-阿贝洛有限公司 重组Bet.V.1过敏原突变体及其方法和制备
MXPA05005528A (es) * 2002-11-26 2006-04-05 Alk Abello As Producto farmaceutico de alergeno.

Also Published As

Publication number Publication date
EP1812059A2 (en) 2007-08-01
US20060121064A1 (en) 2006-06-08
PL1812059T3 (pl) 2010-10-29
AU2005304107A1 (en) 2006-05-18
HK1108568A1 (en) 2008-05-09
WO2006050729A2 (en) 2006-05-18
JP2008519776A (ja) 2008-06-12
JP5628473B2 (ja) 2014-11-19
MX2007005523A (es) 2007-07-05
ATE468135T1 (de) 2010-06-15
CA2586283A1 (en) 2006-05-18
EP1812059B1 (en) 2010-05-19
AU2005304107B2 (en) 2011-06-02
WO2006050729A3 (en) 2006-08-24

Similar Documents

Publication Publication Date Title
DE602005021388D1 (de) Verfahren für die präventive behandlung von allergien durch verabreichung einer allergie-vakzine auf die schleimhäute
DE502005010615D1 (de) Mittel zur behandlung von entzündlichen erkrankungen
ATE519488T1 (de) Aminopyrazin-analoga zur behandlung von glaukomen und anderen durch rho-kinase verursachten krankheiten
DE602006007093D1 (de) Kombinationstherapie zur Behandlung von Diabetes und dadurch bedingten Leiden sowie zur Behandlung von mittels Erhöhung des GLP-1-Spiegels im Blut verbesserten Leiden
NO20083780L (no) Topisk sammensetning omfattende en antibakteriell substans
ATE395052T1 (de) Verwendung von c-kit-inhibitoren für die behandlung von typ-2-diabetes
ATE447574T1 (de) 3-amino-4-phenylbutansäurederivate als dipeptidylpeptidase-hemmer zur behandlung oder vorbeugung von diabetes
DE602004028841D1 (de) Purin nucleoside für die behandlung von durch flavividrae verursachten krankheiten, einschliesslich hepatitis c
EA201101187A1 (ru) Антидиабетические лекарственные средства, содержащие ингибитор dpp-4 (линаглиптин) необязательно в комбинации с другими антидиабетическими средствами
EA200802054A1 (ru) Ингибиторы фермента
SE0301882D0 (sv) New use I
NO20083032L (no) Anvendelse av benzofuserte heterocykliske sulfamidderivater for behandling av mani og bipolar forstyrrelse
DE602005007746D1 (de) Nukleinsäuren zur behandlung von erkrankungen im zusammenhang mit hmgb1
ATE538651T1 (de) Spiropiperidininhibitoren von beta-secretase zur behandlung von alzheimer-krankheit
DE112004000961D2 (de) Verwendung von Wirksubstanzen zur Vorbeugung oder Behandlung von Viruserkrankungen sowie Testsystem zum Auffinden solcher Wirksubstanzen
DE602006010442D1 (de) Verwendung von benzokondensierten heterocyclischen sulfamid-derivaten zur behandlung von schmerzen
ATE446285T1 (de) Für die behandlung von alzheimer-krankheit und ähnlichen leiden geeignete 1-alkyl-3- thiosubstituierte indol-2-alkinsäuren
ATE464895T1 (de) Verwendung von benzokondensierten heterocyclischen sulfamid-derivaten zur behandlung von depressionen
NO20080781L (no) GLEPP-inhibitorer i behandlingen av autoimmune og/eller inflammatoriske sykdommer
DE60334094D1 (de) Verwendung von pleuromutilinen zur behandlung von erkrankungen, die durch helicobacter pylori verursacht werden
ATE542804T1 (de) 5-phenyl-pentansäurederivate als matrixmetalloproteinase-inhibitoren zur behandlung von asthma und anderen erkrankungen
ATE445644T1 (de) Anwendung von molekülen und verfahren zur behandlung von mit mcp-1/ccr2 assoziierten krankheiten
DE60325275D1 (de) Verwendung des menschlichen choriongonadotropins in der behandlung von endometriose-symptomen
ATE392212T1 (de) Verwendung eines proteasom-inhibitors zur behandlung fibrotischer erkrankungen
DE502004012196D1 (de) Verwendung von isorhamnetin zur behandlung von depressiven verstimmungen und erkrankungen

Legal Events

Date Code Title Description
8363 Opposition against the patent